Skip to content

What plant is ivermectin made from? The surprising truth about its microbial origins

3 min read

Despite common assumptions, ivermectin is not made from a plant at all, but rather derived from a microbe first discovered in a Japanese soil sample. This discovery by microbiologist Satoshi Ōmura led to the development of a 'wonder drug' that has had an immense impact on global public health.

Quick Summary

Ivermectin is a semisynthetic drug, originating from compounds produced by the soil bacterium Streptomyces avermitilis. It was developed by chemically modifying the naturally occurring avermectins, not by extracting them from any plant material.

Key Points

  • Microbial origin: Ivermectin is derived from the compounds produced by the soil bacterium Streptomyces avermitilis, not from a plant.

  • Semisynthetic drug: The drug is considered semisynthetic because it involves fermentation of the naturally occurring microbe, followed by a chemical modification to produce the final compound.

  • Nobel Prize discovery: Researchers Satoshi Ōmura and William C. Campbell were awarded the 2015 Nobel Prize for their work related to the discovery and development of avermectins and ivermectin.

  • Japanese soil sample: The originating bacterium was isolated from a soil sample collected near a golf course in Japan in the 1970s.

  • Broad-spectrum use: Ivermectin is a powerful antiparasitic agent used in both veterinary medicine and human health to treat a wide range of parasitic infections.

  • Impact on global health: The drug has significantly reduced the prevalence of devastating parasitic diseases like river blindness and lymphatic filariasis worldwide.

In This Article

Contrary to a popular misconception, what plant is ivermectin made from? is a trick question. The medication does not come from a plant, but from a microbe discovered in soil. Its active compounds were isolated from the soil-dwelling bacterium Streptomyces avermitilis, which was found in a soil sample in Japan. This discovery and subsequent development of the drug led to the 2015 Nobel Prize in Physiology or Medicine for researchers Satoshi Ōmura and William C. Campbell.

The Discovery of a Microbial 'Wonder Drug'

The story of ivermectin begins in the 1970s with a collaborative research project between Japan's Kitasato Institute and the pharmaceutical company Merck & Co. Microbiologist Satoshi Ōmura collected thousands of soil samples from across Japan in search of new antibacterial agents. One particular sample, collected near a golf course southwest of Tokyo, yielded a microorganism that produced a new and potent class of antiparasitic compounds.

This new microbe was identified as a species of actinomycete and named Streptomyces avermitilis. The potent compounds it produced were named avermectins. Researchers at Merck, led by William C. Campbell, then undertook the task of isolating and testing these compounds against various parasites. They discovered that avermectin was highly effective, and further chemical modification was performed to increase its safety and efficacy, resulting in the drug we now know as ivermectin.

The Semisynthetic Production Process

Ivermectin is classified as a semisynthetic drug because it involves both a natural source (the microbe) and a chemical modification process. The production is a multistep process involving fermentation and chemical engineering.

  • Fermentation: Large-scale bioreactors are used to grow cultures of Streptomyces avermitilis, which produce the natural avermectin compounds.
  • Isolation: The crude avermectins are then isolated from the fermentation broth.
  • Chemical Modification: The isolated avermectin, primarily avermectin B1a, undergoes a chemical process called hydrogenation to create the more active and stable ivermectin.

This precise and controlled manufacturing process is what yields the final pharmaceutical product used in both veterinary and human medicine.

Microbial vs. Plant-Derived Medications

Many medicines, like ivermectin, are naturally sourced but do not come from plants. Below is a comparison of ivermectin's origin with that of a well-known plant-derived medication, artemisinin, to highlight the difference.

Feature Ivermectin Artemisinin
Natural Source Streptomyces avermitilis (soil bacterium) Artemisia annua (sweet wormwood plant)
Originating Organism Microorganism (bacterium) Plant
Method of Production Fermentation followed by chemical modification (semisynthetic) Extraction from plant matter
Primary Use Antiparasitic (worms, insects) Antimalarial
Nobel Prize Connection Yes, 2015 for discovery and development Yes, 2015 for discovery

The Broad Impact of Ivermectin

Initially developed for veterinary use, where it became a top-selling drug for treating parasites in livestock and pets, ivermectin's impact quickly expanded to human health. It proved to be a powerful tool against parasitic diseases that disproportionately affect impoverished populations in tropical regions. For example, ivermectin is a cornerstone of global campaigns to eliminate diseases like river blindness (onchocerciasis) and lymphatic filariasis. The drug's safety and effectiveness have made mass drug administration programs possible, dramatically reducing the burden of these diseases and earning its 'wonder drug' reputation.

Conclusion: Understanding the True Source of Ivermectin

Understanding where medications come from is crucial for appreciating the scientific process behind modern pharmacology. The story of what plant is ivermectin made from? serves as an excellent case study. The answer is, in fact, not a plant at all, but rather a remarkable journey from a single soil sample to a life-changing medication. The discovery and development of this semisynthetic drug highlight the importance of natural product screening and microbial research in creating effective treatments for major global health issues. The collaborative efforts of researchers like Ōmura and Campbell turned a microbial compound into a vital tool for human and animal health, underscoring the potential hidden in the smallest corners of our natural world.

Learn more about the fascinating history and impact of ivermectin from the National Institutes of Health: Ivermectin, 'Wonder drug' from Japan: the human use perspective article

Frequently Asked Questions

The microbe that produces the precursor compounds, known as avermectins, is the soil bacterium Streptomyces avermitilis.

The specific strain of Streptomyces avermitilis was isolated from a soil sample collected in Japan in the 1970s.

It is called semisynthetic because it is not purely natural or purely synthetic. The process starts with a naturally produced compound (avermectin from the microbe) that is then chemically modified in a lab to produce the final drug, ivermectin.

The discovery was a collaborative effort. Microbiologist Satoshi Ōmura isolated the microorganism, while parasitologist William C. Campbell and his team at Merck discovered the compounds' antiparasitic activity.

The conversion involves a selective hydrogenation process in a laboratory setting to chemically modify the naturally produced avermectin into the more stable and effective ivermectin.

Avermectins are the natural compounds produced by the soil bacterium Streptomyces avermitilis. Ivermectin is a refined, semisynthetic derivative of avermectin, developed for increased activity and safety.

No, ivermectin has no relation to plant-based medications. While both ivermectin and artemisinin were recognized by the Nobel committee in 2015, they come from entirely different sources: ivermectin from a bacterium and artemisinin from a plant (Artemisia annua).

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.